Corgenix Medical Corp. has entered into a collaboration with Eli Lilly and Co. to develop diagnostic technology to support a Lilly oncology program. The two companies will collaborate to further advance this diagnostic technology originally developed by Lilly. Financial terms were not disclosed.   “We are very pleased to enter into this new and exciting collaboration with Lilly,” said Douglass Simpson, president and chief executive officer of Corgenix, “This relationship strengthens our company’...